Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inflammatory risk after myocardial infarction: the fire that persists.

American journal of preventive cardiology·2026

Same author

Cardiometabolic protective mechanisms and efficacy of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in SLE.

Rheumatology (Oxford, England)·2026

Same author

Prognostic Value of Coronary CT Angiography Among Patients With and Without Diabetes: The Mass General Brigham CCTA registry.

Cardiovascular diabetology·2026

Same author

Incremental Prognostic Value of Subendocardial Myocardial Flow Reserve in Patients With Normal Perfusion.

Circulation·2026

Same author

Evaluation and treatment of pericardial disease in immune-mediated inflammatory diseases.

Rheumatology (Oxford, England)·2026

Same author

The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC).

Journal of the American College of Cardiology·2026

Search research articles

Related Experiment Video

Updated: Feb 17, 2026

Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

Published on: July 21, 2023

Evolving Areas in Heart Transplantation.

Brittany N Weber¹, Jon A Kobashigawa², Michael M Givertz¹

¹Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

JACC. Heart Failure

|December 2, 2017

Summary

Heart transplantation has evolved significantly over 50 years, improving surgical techniques and patient care. Future advancements include xenotransplantation, stem cells, and artificial hearts for cardiac replacement therapy.

Keywords:

cardiac allograft vasculopathy heart transplantation immunosuppression stem cells tissue engineering transplant rejection

More Related Videos

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice

Published on: January 23, 2016

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

Related Experiment Videos

Last Updated: Feb 17, 2026

Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

Published on: July 21, 2023

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice

Published on: January 23, 2016

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

Area of Science:

Cardiology
Transplant Surgery
Immunology

Background:

The first human-to-human heart transplant occurred in 1967, marking a milestone in cardiac surgery.
Significant advancements have since transformed heart transplantation practices.

Purpose of the Study:

To provide a perspective on the evolution of heart transplantation.
To highlight key advancements and future directions in cardiac replacement therapy.

Main Methods:

Review of historical progress in heart transplantation.
Discussion of current and emerging cardiac replacement therapies.

Main Results:

Progress in surgical techniques, immunosuppression, donor/recipient selection, and post-transplant care.
Key areas of focus include rejection screening, cardiac allograft vasculopathy, and novel therapies.

Conclusions:

Heart transplantation has undergone remarkable transformation over five decades.
Future innovations like xenotransplantation, stem cells, tissue engineering, and total artificial hearts promise further advancements in cardiac replacement.